Search

Your search keyword '"Zamani, Omid"' showing total 114 results

Search Constraints

Start Over You searched for: Author "Zamani, Omid" Remove constraint Author: "Zamani, Omid"
114 results on '"Zamani, Omid"'

Search Results

6. Well Integrity in Salt Cavern Hydrogen Storage.

10. Does the internet bring food prices closer together? Exploring search engine query data in Iran.

11. Exploring the impact of dust storms on pastoralists' livelihoods in West Iran: Social, economic, and environmental consequences.

21. Food markets performance under the COVID-19 pandemic: a case study of meat industry in Iran.

22. A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE Study

26. HIV Continuum of Care Among People Who Inject Drugs in Iran

30. EU exports of livestock products to West Africa: An analysis of dairy and poultry trade data

33. To Ban or not to Ban? Implications of the Recent Ban on Poultry Imports by Ghana

37. Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study

38. A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study

39. The role of temperature for seasonal market integration: a case study of poultry in Iran*.

40. A Phase Iii, Randomized, Placebo-Controlled Study of Belimumab, a Monoclonal Antibody That Inhibits B Lymphocyte Stimulator, in Patients With Systemic Lupus Erythematosus

41. Optimise: An Austrian Multicentre Study on the Effectiveness and Safety of Tocilizumab in Combination with Methotrexate versus Tocilizumab for Mild/Moderate Rheumatoid Arthritis and an Inadequate Response to Methotrexate

47. Economic sanctions, energy consumption, and CO2 emissions in Iran: a system dynamics model.

48. Efficacy and Safety of Baricitinib (BARI) in Patients with Active Rheumatoid Arthritis (RA) and Inadequate Response (IR) to Tumour Necrosis Factor inhibitors (TNFi): Summary Results from the 24-week Phase 3 RA-BEACON study

49. 216. BARICITINIB, METHOTREXATE, OR BARICITINIB PLUS METHOTREXATE IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE RHEUMATOID ARTHRITIS WHO HAD RECEIVED LIMITED OR NO TREATMENT WITH DMARDS: EFFICACY AND SAFETY RESULTS FROM THE 52-WEEK PHASE 3 RA-BEGIN STUDY

50. Efficacy and Safety of Baricitinib in Patients with Active Rheumatoid Arthritis and Inadequate Response to Tumour Necrosis Factor Inhibitors

Catalog

Books, media, physical & digital resources